Life sciences news
-
Precirix partners with Evergreen to expand North American clinical trial supply
Wednesday April 28th 2021
Read more
-
ViroVet successful with second vaccine based on new vaccine technology, Rega Institute assesses development of human version
Monday March 22nd 2021
Read more
-
Consortium led by eTheRNA immunotherapies awarded EU Commission TIGER Grant of EUR 6.9 million
Sunday March 21st 2021
Read more
-
Galapagos reports primary endpoint for the ongoing filgotinib MANTA and MANTA-RAy safety studies
Thursday March 4th 2021
Read more
-
Galapagos and Gilead discontinue ISABELA Phase 3 trials in IPF
Thursday February 11th 2021
Read more
-
VUB scientist Mathieu Vinken coordinates prestigious European research into animal-free methods for testing chemical substances
Wednesday February 3rd 2021
Read more
-
argenx announces “GO” Decision in ADHERE trial of Efgartigimod in Chronic Inflammatory Demyelinating Polyneuropathy following interim analysis
Tuesday February 2nd 2021
Read more
-
Bone Therapeutics treats first patient in ALLOB Phase IIb tibial fracture study
Tuesday January 12th 2021
Read more
-
Become a flanders.bio member
Your news here?
-
Bone Therapeutics completes recruitment and patient treatment in JTA-004 pivotal Phase III knee osteoarthritis study
Tuesday December 22nd 2020
Read more
-
Mithra announces positive DSMB safety review and continuation of its Phase III Clinical Program Donesta® in menopause
Wednesday December 16th 2020
Read more
-
Galapagos announces first dosing in MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease
Thursday December 3rd 2020
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
